These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8456415)

  • 21. The role of immunotherapy in type I diabetes mellitus.
    Geffner ME; Lippe BM
    West J Med; 1987 Mar; 146(3):337-43. PubMed ID: 3554759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prospects of immunosuppression in type I diabetes.
    Bach JF; Feutren G; Boitard C
    Adv Nephrol Necker Hosp; 1988; 17():321-40. PubMed ID: 3124546
    [No Abstract]   [Full Text] [Related]  

  • 23. [Results of cyclosporin A therapy in the early phase of type I diabetes mellitus].
    Schernthaner G; Aschauer-Treiber G; Gaube S; Klösch-Kasparek D; Müller C; Zielinski C
    Wien Klin Wochenschr; 1988 Jun; 100(13):454-9. PubMed ID: 3043916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Autoimmune thyroid pathology in recently diagnosed diabetes mellitus type 1].
    Molina Lacasa A; Fernández Castañer M; Pérez Maraver M; López Jiménez L; Gómez Sáez JM; Soler Ramón J
    Rev Clin Esp; 1998 Dec; 198(12):818-21. PubMed ID: 9930003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
    Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
    Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dendritic cell mediated therapy for immunoregulation of type 1 diabetes mellitus.
    Phillips BE; Giannoukakis N; Trucco M
    Pediatr Endocrinol Rev; 2008 Jun; 5(4):873-9. PubMed ID: 18552749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Latent autoimmune (Type-1) diabetes mellitus in adults. Part. I. Serologic markers of autoimmune involvement of pancreatic beta-cells: GADA, ICA, IA-2 a IA-A].
    Martinka E; Ocenásová A; Straková J; Mokán M
    Vnitr Lek; 1999 Feb; 45(2):97-102. PubMed ID: 15641228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-mediated immunity in type I (insulin-dependent) diabetes of man and the BB rat.
    Naji A; Silvers WK; Barker CF
    Concepts Immunopathol; 1985; 2():32-46. PubMed ID: 3916413
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunotherapy for insulin-dependent diabetics?
    Rossini AA
    N Engl J Med; 1983 Feb; 308(6):333-5. PubMed ID: 6337326
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunologic aspects of type I diabetes.
    Dobersen MJ; Chase HP
    Pediatrician; 1983-1985; 12(4):173-8. PubMed ID: 6400449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Canine immune-mediated diabetes mellitus: a case report.
    Elie M; Hoenig M
    J Am Anim Hosp Assoc; 1995; 31(4):295-9. PubMed ID: 7552660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Autoimmunity and glutamate decarboxylase antibodies in the pathogenesis of type I diabetes mellitus in experimental and clinical practice].
    Kucera P; Andĕl M; Treslová L
    Vnitr Lek; 1996 May; 42(5):359-67. PubMed ID: 8768297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes.
    Bergerot I; Fabien N; Thivolet C
    Diabetes Metab; 1996 Jul; 22(4):235-9. PubMed ID: 8767168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caspase-3-dependent beta-cell apoptosis in the initiation of autoimmune diabetes mellitus.
    Liadis N; Murakami K; Eweida M; Elford AR; Sheu L; Gaisano HY; Hakem R; Ohashi PS; Woo M
    Mol Cell Biol; 2005 May; 25(9):3620-9. PubMed ID: 15831467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humoral autoimmune aspects of insulin-dependent (type I) diabetes mellitus.
    Dobersen MJ
    Concepts Immunopathol; 1985; 2():47-64. PubMed ID: 3916414
    [No Abstract]   [Full Text] [Related]  

  • 36. Specificity of islet cell autoantibodies and coexistence with other organ specific autoantibodies in type 1 diabetes mellitus.
    Tsirogianni A; Pipi E; Soufleros K
    Autoimmun Rev; 2009 Jul; 8(8):687-91. PubMed ID: 19217947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-cell regulation in murine and human autoimmune diabetes: the role of TH1 and TH2 cells.
    Heurtier AH; Boitard C
    Diabetes Metab; 1997 Nov; 23(5):377-85. PubMed ID: 9416429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy.
    Reddy S; Young M; Poole CA; Ross JM
    Gen Comp Endocrinol; 1998 Jul; 111(1):9-19. PubMed ID: 9653017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
    Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Etiology and pathogenesis of insulin-dependent diabetes mellitus].
    Klöppel G; Clemens A
    Verh Dtsch Ges Pathol; 1996; 80():93-103. PubMed ID: 9065059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.